Funding
Turn ideas into impact
Show Me
Due: October 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
US $750,000
Type
Grant
Source
Federal
Opp Number
PAR-25-060
Due: October 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
US $750,000
Type
Grant
Source
Federal
Opp Number
PAR-25-059
Due: October 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-225
Due: October 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-353
Due: October 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-352
Due: October 25, 2027
New
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
US $375,000
Type
Grant
Source
Federal
Opp Number
PAR-27-078
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program(R34 Clinical Trials Optional)
US $600,000
Type
Grant
Source
Federal
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
US $600,000
Type
Grant
Source
Federal
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-103
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?